We have invested in over 30 portfolio companies, with 11 successfully listed on stock markets, establishing ourselves as one of the top-performing healthcare private equity funds.
In Medtech, we specialize in high-growth segments including endoscopy, cardiovascular interventional therapies, and electrophysiology, partnering with both listed leaders and emerging innovators to advance minimally invasive technologies and precision medicine.
In Life Sciences & Biotech, we target cutting-edge areas including gene therapy, biopharmaceuticals, and high-end biological reagents, driving innovation through cross-border partnerships and supporting the global expansion of biotech companies.